Novo Rebrands Diabetes Pill as Ozempic to Tap Blockbuster Name
Novo Nordisk A/S is rebranding an existing, less-popular diabetes tablet as Ozempic in the US in a bid…
Novo Says Priority Is Obesity Despite Investor Calls to Expand
Novo Nordisk A/S is doubling down on obesity and diabetes, putting it at loggerheads with investors calling for…